Moreover, immunohistochemical analysis of tumor sections strengthened this observation, because metformin treatment enhanced protein levels of CD31, an endothelial marker (Figure 2E and 2F), and increased the serum level of VEGF (Figure 2G), suggesting that metformin promotes angiogenesis in melanoma tumors. Here, PECAM1 is linked to neoplasm.